Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Healthcare Company (ACHC) Payables (2016 - 2025)

Acadia Healthcare Company (ACHC) has disclosed Payables for 16 consecutive years, with $150.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Payables fell 35.37% to $150.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $150.4 million, a 35.37% decrease, with the full-year FY2025 number at $150.4 million, down 35.37% from a year prior.
  • Payables was $150.4 million for Q4 2025 at Acadia Healthcare Company, down from $179.9 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $232.7 million in Q4 2024 to a low of $85.9 million in Q3 2021.
  • A 5-year average of $140.6 million and a median of $137.3 million in 2023 define the central range for Payables.
  • Peak YoY movement for Payables: surged 49.09% in 2023, then crashed 35.37% in 2025.
  • Acadia Healthcare Company's Payables stood at $98.6 million in 2021, then grew by 6.24% to $104.7 million in 2022, then skyrocketed by 49.09% to $156.1 million in 2023, then surged by 49.04% to $232.7 million in 2024, then plummeted by 35.37% to $150.4 million in 2025.
  • Per Business Quant, the three most recent readings for ACHC's Payables are $150.4 million (Q4 2025), $179.9 million (Q3 2025), and $219.8 million (Q2 2025).